This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
The 2024 AACR Annual Meeting is coming up soon! Join us in San Diego from April 5-10 for the annual event. Every year, the cancer research community gathers to share the latest advances in cancer science and medicine at the AACR Annual Meeting.
Drop by Booth #804 to pick up technical resources and an adorable Dr. Booster figurine! Come and discover how our products and services can boost your research. We look forward to seeing you there...
Meet us in Salt Lake City from March 10-14 at the Society of Toxicology (SOT) 63rd Annual Meeting and ToxExpo! Over 5,000 toxicologists and professionals attend this event to share the latest science and technology advancements, make new connections, and engage in professional development.
Stop by Booth #1802 to pick up technical resources and an adorable Dr. Booster figurine! Come and discover how our products, services, and resources can boost your research. We hope to see you there...
Season’s greetings from the entire Boster team!
May your holidays be full of love, joy, and hope. Wishing you peace, happiness, and success in the new year!
Thank you for your support in 2023 and we look forward to continuing to serve you in the upcoming year.
Have a Merry Christmas and a Happy New Year...
Welcome to the latest issue of Research Spotlight! We're excited to dive into biomedical breakthroughs that are impacting health and disease research.
In the field of neuroscience, research revealed how stress affects the brain, particularly the red nucleus, and its link to anxiety and immune responses. This insight has implications for treating mental health disorders. In respiratory research, a new study advanced our understanding of how the lungs detect allergens, opening up possibilities...
Stock up on primary antibodies and ELISA kits with our holiday sale! From now until the end of 2023, we're offering 50% OFF on all PicoKine® ELISA kits and Picoband™ antibodies!
When placing your order, submit the promo code PICO50 at checkout, or through phone or email, to apply the 50% discount.
The promotion ends on December 31, 2023. Take advantage of...
Welcome to this month’s Research Spotlight! In this issue, we are excited to showcase our customers’ new studies that are shaping the future of biomedicine.
In the field of neurology, researchers investigated a critical pathway, p300/NF-κB/NLRP3, impacted by disruptions in chaperone-mediated autophagy, which holds promise for treatments in neurodegenerative diseases. For regenerative medicine, scientists introduced a metal-organic framework-incorporated hydrogel that...
Neuroscience 2023 is taking place in Washington, D.C. at Walter E. Washington Convention Center from November 11-15. Join 30,000 scientists from around the world to discover hot topics and tools for neuroscience!
Meet us at Booth# 2104 to pick up some Boster goodies including pathway posters, technical resources, free phone accessories, and a Dr. Booster plush doll!
Come and discover how our products, services, and resources can boost your research. We hope to see you there...
As autumn leaves turn golden, Boster Bio is excited to present a medley of pioneering studies that have recently been published. This month’s issue covers a spectrum from novel therapeutic interventions to insightful multi-omics analyses.
In the therapeutic domain, we spotlight a novel implantable hydrogel-based sensor that allows for real-time drug monitoring in rats. We also observe a shift in cancer treatments with a new cocktail nanovaccine. Additionally, fresh approaches are introduced for targeting lung fibrosis using mitochondrial transfer and enhancing liver cancer treatments with artesunate.
On a molecular scale, studies revealed how indoor air pollutants impact liver health and blood lipid levels. Scientists also investigated the protective role of gut fungi against intestinal issues and the potential of mung bean sprout nanoparticles in diabetes management. Moreover, recent findings linked a compound in the colon, phosphocholine, with a specific fungus Candida tropicalis, highlighting mycobiota’s importance for our digestive health.
Scroll down to learn more about these discoveries!
Authors: Li, S., Dai, J., Zhu, M., Currás, N.A., Li, H., Wang, Y., Wang, Q…
Journal: ACS Nano
The ability to track the levels of specific molecules, such as drugs, metabolites, and biomarkers, in the living body, in real time and for long durations, would improve our understanding of health and our ability to diagnose, treat, and monitor disease. To this end, we are developing electrochemical aptamer-based (EAB) biosensors...
Cited Boster Product(s): Rat IL-12(P70) ELISA Kit PicoKine® (EK1652); Rat Endothelin 1/EDN1 ELISA Kit PicoKine® (EK0952)
Authors: Huang, T., Lin, R., Su, Y., Sun, H., Zheng, X., Zhang, J., Lu, X…
Journal: Nature Communications
The use of exogenous mitochondria to replenish damaged mitochondria has been proposed as a strategy for the treatment of pulmonary fibrosis. However, the success of this strategy is partially restricted by the difficulty of supplying sufficient mitochondria to diseased cells. Herein, we report the generation of high-powered mesenchymal...
Cited Boster Product(s): Mouse MMP-9 ELISA Kit PicoKine® (EK0466); Mouse TGF Beta 1 ELISA Kit PicoKine® (EK0515); 4% Paraformaldehyde (PFA) Solution In PBS (AR1068); Anti-Ki67/MKI67 Antibody Picoband™ (PB9026); Goat Anti-Rabbit IgG (H+L) Secondary Antibody, FITC Conjugated (BA1105)
Authors: Liu, M., Xie, D., Hu, D., Zhang, R., Wang Y., Tang, L., Zhou, B…
Journal: Advanced Science
In situ vaccination is a desirable strategy for cancer immunotherapy due to its convenience and capacity to target tumor antigens. Here, an in situ nanovaccine based on a cationic peptide with cholesterol-modified, DP7-C, for cancer immunotherapy is rationally designed, and developed a cancer nanovaccine that is easy to preparate...
Cited Boster Product(s): Mouse TNF Alpha/Tumor Necrosis Factor ELISA Kit PicoKine® (EK0527)
Authors: Ma, Z., Chen, W., Liu, Y., Yu, L., Mao, X., Guo, X., Jiang, F., Guo, Q…
Journal: Autophagy
Sorafenib is the most widely used first-line drug for the treatment of the advanced hepatocellular carcinoma (HCC). Unfortunately, sorafenib resistance often limits its therapeutic efficacy. To evaluate the efficacy of artesunate against sorafenib-resistant HCC and to investigate its underlying pharmacological mechanisms...
Cited Boster Product(s): Citrate Buffer Powder (AR0024)
Authors: Zhang, B., Ren, Z., Zhao, J., Zhu, Y., Huang, B., Xiao, C., Zhang, Y…
Journal : Theranostics
Background: Advanced non-small cell lung cancer (NSCLC) is the most common type of lung cancer with poor prognosis. Adoptive cell therapy using engineered T-cell receptors (TCRs) targeting cancer-testis antigens, such as Melanoma-associated antigen 3 (MAGE-A3), is a potential approach for the treatment of NSCLC. However, systematic...
Cited Boster Product(s): HRP Conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) (BA1054)
Authors: Miao, G., Wang, Y., Wang, B., Yu, H., Liu, J., Pan, R., Zhou, C…
Journal: Environment International
As a widespread indoor air pollutant, volatile organic compound (VOC) caused various adverse health effects, especial the damage to liver, which has become a growing public concern. However, the current toxic data are intrinsically restricted in the single or major VOC species. Limited knowledge is available regarding toxic effects...